Rhythm Biosciences Limited (RHY) is a medical diagnostics company aimed at delivering simple, affordable blood tests for accurate and early detection of cancers. It is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer, and saving lives.
Find out what a historical investment in Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt would be worth today using our RHYOA stock calculator.
Buying RHYOA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in RHYOA
What is the ticker symbol of Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt?
The ticker symbol for Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt is RHYOA.
How much is one share of RHYOA?
One share of RHYOA is valued at $0.01 as of 20 November 2026.
What is the market capitalisation of Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt RHYOA?
As of 20 November 2026 Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt has a market cap of $21.23M.
What is the P/E ratio of RHYOA?
The Price to Earnings ratio of RHYOA is -0.56.
What is the Earnings Per Share of RHYOA?
The Earnings Per Share of RHYOA is -$0.02.
What is the 52-week high for Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt stock?
The Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt 52-week high stock price is $0.13.
What is the 52-week low for Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt stock?
The Rhythm Biosciences Call 0.2 AUD Rhythm Biosciences 30Nov27 Opt 52-week low stock price is $0.01.
Can I buy RHYOA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RHYOA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.